{
    "clinical_study": {
        "@rank": "5078", 
        "brief_summary": {
            "textblock": "To determine the efficacy and toxicity of the combination of mitoxantrone hydrochloride (\n      Novantrone ) and etoposide in the treatment of patients with HIV associated lymphomas."
        }, 
        "brief_title": "Phase II Study of Novantrone(R) (Mitoxantrone) and Etoposide in Patients With HIV Associated Large Cell and Immunoblastic Lymphomas", 
        "condition": [
            "Lymphoma, Non-Hodgkin", 
            "HIV Infections"
        ], 
        "condition_browse": {
            "mesh_term": [
                "HIV Infections", 
                "Acquired Immunodeficiency Syndrome", 
                "Lymphoma", 
                "Lymphoma, Non-Hodgkin", 
                "Lymphoma, Large-Cell, Immunoblastic"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria\n\n        Patients must have the following:\n\n          -  Positive HIV antibody, positive HIV culture or antigen capture, or prior diagnosis of\n             AIDS by the CDC criteria.\n\n          -  Diagnosis by pathological examination of large cell or immunoblastic lymphoma within\n             measurable or evaluable disease.\n\n          -  Pneumocystis carinii pneumonia (PCP) prophylaxis during the course of the study.\n\n          -  Signed written informed consent.\n\n        Exclusion Criteria\n\n        Co-existing Condition:\n\n        Patients with the following conditions or symptoms are excluded:\n\n          -  Acute intercurrent opportunistic infection, such as Pneumocystis carinii pneumonia\n             (PCP) diagnosed within 3 weeks.\n\n          -  Stage IE Central Nervous System lymphomas.\n\n        Patients with the following are excluded:\n\n          -  More than one previous treatment for lymphoma.\n\n          -  Acute intercurrent opportunistic infection, such as Pneumocystis carinii pneumonia\n             (PCP) diagnosed within 3 weeks.\n\n          -  Conditions that preclude obtaining an informed consent.\n\n          -  Not accessible for scheduled treatment visits or follow-up.\n\n          -  Stage IE Central Nervous System (CNS) lymphomas.\n\n        Prior Medication:\n\n        Excluded within 2 weeks of study entry:\n\n          -  Zidovudine.\n\n          -  Excluded:\n\n          -  Doxorubicin dosing = or > 300 mg/m2.\n\n        Prior Treatment:\n\n        Excluded:\n\n          -  Received more than one previous treatment regimen for lymphoma.\n\n        Required:\n\n          -  Prophylactic treatment for Pneumocystis carinii pneumonia (PCP) prophylaxis."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "firstreceived_date": "November 2, 1999", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT00002003", 
            "org_study_id": "055A", 
            "secondary_id": "3-100"
        }, 
        "intervention": [
            {
                "intervention_name": "Mitoxantrone hydrochloride", 
                "intervention_type": "Drug"
            }, 
            {
                "intervention_name": "Etoposide", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Etoposide", 
                "Etoposide phosphate", 
                "Mitoxantrone"
            ]
        }, 
        "keyword": [
            "Mitoxantrone", 
            "Lymphoma, Large-Cell", 
            "Etoposide", 
            "Acquired Immunodeficiency Syndrome"
        ], 
        "lastchanged_date": "June 23, 2005", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Newark", 
                        "country": "United States", 
                        "state": "New Jersey", 
                        "zip": "071032714"
                    }, 
                    "name": "UMDNJ - New Jersy Med School"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "New York", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "10019"
                    }, 
                    "name": "Saint Luke's - Roosevelt Hosp Ctr"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "New York", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "10016"
                    }, 
                    "name": "New York Univ Med Ctr"
                }
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "official_title": "Phase II Study of Novantrone(R) (Mitoxantrone) and Etoposide in Patients With HIV Associated Large Cell and Immunoblastic Lymphomas", 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration"
        }, 
        "phase": "Phase 2", 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00002003"
        }, 
        "source": "NIH AIDS Clinical Trials Information Service", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Lederle Laboratories", 
                "agency_class": "Industry"
            }
        }, 
        "study_design": "Endpoint Classification: Efficacy Study, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "March 1992"
    }, 
    "geocoordinates": {
        "New York Univ Med Ctr": "40.714 -74.006", 
        "Saint Luke's - Roosevelt Hosp Ctr": "40.714 -74.006", 
        "UMDNJ - New Jersy Med School": "40.736 -74.172"
    }
}